Supply Issues Pajunk UK Medical Products Ltd NRFit Spinal Needles (ICN 2912)

• The supply issue with NRFit Spinal Needles from Pajunk UK Medical Products Ltd is continuing.
• One product code is no longer suspended and is now subject to intermittent supply:
  • FTR2310.
• Two products remain subject to intermittent supply:
  • FTR2312 and FTR2313.
• Four products remain subject to Protect Demand Management:
  • FTR2297, FTR2303, FTR2314 and FTR2317.
• Seven product codes remain affected in total.
• FTR2297, FTR2303, FTR2314 and FTR2317 are available to order through NHS Supply Chain. However, trusts are allocated a maximum daily quantity or “threshold” to ensure fair supply of available stock across the NHS.
• Potential indirect alternative products are available to order through our online catalogue for the affected products. However, some of these products may also become subject to intermittent supply with the increase in demand.
• See our Downloads ▼ section to access the product listing for further information on the affected product codes and potential alternatives.
• We will continue to review the stock to minimise further disruption and will update this ICN as soon as we have further information.
• The supply issue is now anticipated to be resolved by 30 June 2025.

• The supply issue with NRFit Spinal Needles from Pajunk UK Medical Products Ltd is continuing.
• FTR2312 and FTR2313 are now subject to intermittent supply.
• FTR2310 remains suspended and unavailable to order.
• Four product codes remain subject to Protect Demand Management:
  • FTR2297, FTR2303, FTR2314 and FTR2317.
• Seven product codes remain affected in total.
• FTR2297, FTR2303, FTR2314 and FTR2317 are available to order through NHS Supply Chain. However, trusts are allocated a maximum daily quantity or “threshold” to ensure fair supply of available stock across the NHS.
• Potential indirect alternatives are available for most of the products. These products are available to order through our online catalogue, however, some of these products may also be subject to intermittent supply.
• See our Downloads ▼ section to access the product listing for further information on the affected product codes and potential alternatives and for a full list of product codes subject to Protect Demand Management.
• We will continue to review the stock to minimise further disruption and will update this ICN as soon as we have further information.
• The supply issue is now anticipated to be resolved by 9 June 2025.

Change:

• The supplier Pajunk UK Medical Products Ltd has informed us of a supply issue with its NRFit Spinal Needles products.
• Seven products codes are affected:
  • FTR2297
  • FTR2303
  • FTR2310
  • FTR2312
  • FTR2313
  • FTR2314
  • FTR2317
• The supply issue is due to a shortage in raw materials.

Impact:          

• Two products are currently suspended and unavailable to order. Once stock is received, these products will then be threshold managed and will be subject to Protect Demand Management:
  • FTR2310
  • FTR2312
• Four products are subject to Protect Demand Management. They are still available to order through NHS Supply Chain, however, trusts are allocated a maximum daily quantity or “threshold” to ensure fair supply of available stock across the NHS:
  • FTR2297
  • FTR2303
  • FTR2314
  • FTR2317
• One product is subject to intermittent supply:
  • FTR2313
• There are potential indirect alternatives for most of the products. These products are available to order through our online catalogue, however, some of these products may also be subject to intermittent supply.
• We are currently sourcing further alternatives and updates will be made to the product listing when available.
• The supply issue is anticipated to be resolved by 23 May 2025.

Next Steps:               

• See our Downloads ▼ section to access the product listing for further information on the affected product codes and potential alternatives.
• See our Downloads ▼ section for a full list of product codes subject to Protect Demand Management.
• The supply issue is being monitored in conjunction with the supplier and we will continue to review the stock situation to minimise further disruption.
• However, as this is currently a disrupted market and supply is subject to rapid change, the alternatives offered may also be experiencing temporary supply issues and therefore, customers may need to consider clinically reviewing all additional alternatives provided.
• We will update the ICN when we have further information.
• If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.

Please note that due to the clinical nature of these alternative products we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.